Curriculum Vitae
Postdoctoral Scientist: Dr. Fleur Mason
Dr. Fleur Mason
Department of Pharmacology and Toxicology,
University Medical Center Goettingen,
Robert-Koch-Str. 40, 37075 Goettingen
Germany
Tel: +49 (0) 551 3963655
Fax: +49 (0) 551 395699
E-mail: fleur.mason(at)med.uni-goettingen.de
More information on Research Gate
Education & Academic Career
| Education and Academic Career | |
|---|---|
| 2017 - | Postdoctoral Scientist, Department of Pharmacology and Toxicology, University Medical Center Göttingen, Germany |
| 2013 - 2016 | Postdoctoral Scientist, Heart Research Center Göttingen, University of Göttingen, Germany |
| 2013 | PhD, Institute of Cardiovascular Research, University of Manchester, UK, Supervisors: Prof. Andrew Trafford, Prof. David Eisner |
| 2007 - 2009 | Research Assistant, Department of Physiology, Anatomy and Genetics, University of Oxford, UK |
| 2005 | BA(Hons), University of Oxford, UK |
| 2001 - 2002 | Research Technician, Department of Pharmacology, University of Oxford, UK |
Fellowships, Awards and Honours
- 2015: Travel Award, European Society of Cardiology (ESC) Congress 2015, London, UK
- 2011: Travel Award, 35th Annual Meeting of the European Working Group on Cardiac Cellular Electrophysiology, Oslo, Norway
Society Memberships
- Member of the European Society of Cardiology (ESC)
- Member of the Working Group on Cardiac Cellular Electrophysiology (EWGCCE)
- Member of the German Centre for Cardiovascular Research (DZHK)
Selected Publications
- Vettel C, Lindner M, Dewenter M, Lorenz K, Schanbacher C, Riedel M, Lämmle S, Meinecke S, Mason FE, Sossalla S, Geerts A, Hoffmann M, Wunder F, Brunner FJ, Wieland T, Mehel H, Karam S, Lechêne P, Leroy J, Vandecasteele G, Wagner M, Fischmeister R, El-Armouche A. Phosphodiesterase 2 protects against catecholamine-induced arrhythmia and preserves contractile function after myocardial infarction. Circ Res. 2017 120(1):120-132. [PubMed]
- Mason FE, Sossalla S. The significance of the late Na+ current for arrhythmia induction and the therapeutic antiarrhythmic potential of ranolazine. J Cardiovasc Pharmacol Ther. 2016 (Epub ahead of print). [PubMed]
- Hartmann N*, Mason FE*, Braun I, Pabel S, Voigt N, Schotola H, Fischer TH, Dobrev D, Danner BC, RennerA, Gummert J, Belardinelli L, Frey N, Maier LS, Hasenfuss G, Sossalla S. The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology. J Mol Cell Cardiol. 2016 94:95-106. *equal contribution [PubMed]
- Fischer TH, Herting J, Mason FE, Hartmann N, Watanabe S, Nikolaev VO, Sprenger JU, Fan P, Yao L, Popov AF, Danner BC, Schöndube F, Belardinelli L, Hasenfuss G, Maier LS, Sossalla S. Late INa increases diastolic SR-Ca2+-leak in atrial myocardium by activating PKA and CAMKII. Cardiovasc Res. 2015 107(1):184-96. [PubMed]
- Iribe G, Ward CW, Camelliti P, Bollensdorff C, Mason F, Burton RA, Garny A, Morphew MK, Hoenger A, Lederer WJ, Kohl P. Axial stretch of rat single ventricular cardiomyocytes causes an acute and transient increase in Ca2+ spark rate. Circ Res. 2009 104(6):787-95. [PubMed]